Published in Psychol Med on May 30, 2012
Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry (2013) 0.85
Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia. Neurology (2015) 0.80
Migraine, depression, and brain volume: the AGES-Reykjavik Study. Neurology (2013) 0.79
Relationships between Personality Traits, Medial Temporal Lobe Atrophy, and White Matter Lesion in Subjects Suffering from Mild Cognitive Impairment. Front Aging Neurosci (2014) 0.78
Genetic, psychosocial and clinical factors associated with hippocampal volume in the general population. Transl Psychiatry (2014) 0.78
Depression and serum 25-hydroxyvitamin D in older adults living at northern latitudes - AGES-Reykjavik Study. J Nutr Sci (2015) 0.78
The Association Between Midlife Physical Activity and Depressive Symptoms in Late Life: Age Gene/Environment Susceptibility-Reykjavik Study. J Gerontol A Biol Sci Med Sci (2015) 0.78
Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression? Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76
Hippocampal atrophy and subsequent depressive symptoms in older men and women: results from a 10-year prospective cohort. Am J Epidemiol (2014) 0.76
Reconsidering Animal Models of Major Depressive Disorder in the Elderly. Front Aging Neurosci (2016) 0.75
Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies. Prim Care Companion CNS Disord (2014) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Multiple imputation in health-care databases: an overview and some applications. Stat Med (1991) 7.89
Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol (2007) 7.06
Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A (1996) 5.24
Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry (2004) 5.10
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry (2001) 3.24
Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry (1999) 3.15
Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp (2009) 2.55
The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci (2004) 2.43
Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med (2009) 2.42
A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci (2009) 2.41
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology (2010) 2.40
Depression and risk of developing dementia. Nat Rev Neurol (2011) 2.31
Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet (2011) 2.10
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry (2010) 2.03
MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry (2005) 1.93
Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry (2008) 1.91
Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord (2009) 1.82
History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology (2008) 1.64
Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry (2005) 1.51
Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. J Psychiatry Neurosci (2009) 1.49
Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord (2008) 1.49
Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry (2010) 1.45
Hippocampal/amygdala volumes in geriatric depression. Psychol Med (1999) 1.33
Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry (2002) 1.31
An update on regional brain volume differences associated with mood disorders. Curr Opin Psychiatry (2006) 1.30
Brain tissue volumes in the general population of the elderly: the AGES-Reykjavik study. Neuroimage (2011) 1.28
Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res (2004) 1.26
Association of depression and gender with mortality in old age. Results from the Amsterdam Study of the Elderly (AMSTEL). Br J Psychiatry (2000) 1.22
Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI. Proc Natl Acad Sci U S A (1998) 1.19
Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry (2004) 1.12
Depression and cognition in older adults. Curr Opin Psychiatry (2008) 1.10
Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes--the SMART Medea study. Biol Psychiatry (2011) 1.06
Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study. J Affect Disord (2011) 1.02
Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging (2008) 1.01
Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: the SMART-Medea study. Biol Psychiatry (2010) 1.01
A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatry (2011) 0.97
Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder. Acta Psychiatr Scand (2011) 0.92
Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia. J Alzheimers Dis (2012) 0.92
Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc (2000) 10.19
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA (1999) 7.88
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14
Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985) (2001) 5.35
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 3.45
Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) (2005) 3.41
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia (2005) 3.20
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology (2003) 3.18
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study--Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985) (1999) 2.81
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int (2009) 2.53
Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ (1994) 2.51
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res (1996) 2.43
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Reduction in cardiovascular disease risk factors: 6-month results from Project Active. Prev Med (1997) 2.41
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Syncope in migraine: the population-based CAMERA study. Neurology (2006) 2.33
Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation (2001) 2.29
Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet (1997) 2.28
Superhelicity-driven homologous DNA pairing by yeast recombination factors Rad51 and Rad54. Mol Cell (2000) 2.28
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
The impact of migraine on quality of life in the general population: the GEM study. Neurology (2000) 2.24
Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology (2009) 2.21
Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J Bone Miner Res (2001) 2.16
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol (2000) 2.16
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12
Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia (2008) 2.12
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med (1999) 2.09
Dietary diversity and subsequent mortality in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr (1993) 2.09
The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord (2002) 2.08
The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc (2001) 2.04
Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc (2000) 1.99
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Low-grade systemic inflammation in overweight children. Pediatrics (2001) 1.99
The prevalence of functional limitations and disability in older persons in the US: data from the National Health and Nutrition Examination Survey III. J Am Geriatr Soc (2000) 1.99
Body fat and skeletal muscle mass in relation to physical disability in very old men and women of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci (1998) 1.92
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol (1995) 1.87
High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr (1998) 1.82
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology (2002) 1.82
Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol (1997) 1.81
Executive function, memory, and gait speed decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci (2010) 1.80
Memory complaints and memory impairment in older individuals. J Am Geriatr Soc (1996) 1.79
Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci (1998) 1.79
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int (2006) 1.78
Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 1.76
Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology (2004) 1.73
Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health (1998) 1.73
An overview of body weight of older persons, including the impact on mortality. The National Health and Nutrition Examination Survey I--Epidemiologic Follow-up Study. J Clin Epidemiol (1991) 1.71
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer (1999) 1.71
Proximal femur bone mineral levels of US adults. Osteoporos Int (1995) 1.69
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol (1998) 1.67
American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care (2000) 1.64
Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc (2001) 1.61
Characteristics of nondisabled older persons who perform poorly in objective tests of lower extremity function. J Am Geriatr Soc (2000) 1.61
Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? Am J Epidemiol (1995) 1.60
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology (2005) 1.59
Application of bioelectrical impedance analysis to elderly populations. J Gerontol A Biol Sci Med Sci (1997) 1.58
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Epidemiology of Alzheimer's disease. Epidemiol Rev (1992) 1.56
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56
Six-month physical activity and fitness changes in Project Active, a randomized trial. Med Sci Sports Exerc (1998) 1.54
Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Health, Aging, and Body Composition Study Research Group. Ann N Y Acad Sci (2000) 1.54
Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology (1995) 1.45
Genetic basis for clinical expression in multiple sclerosis. Brain (2002) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol (2000) 1.41
Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia (1995) 1.38
Change in muscle mass and muscle strength after a hip fracture: relationship to mobility recovery. J Gerontol A Biol Sci Med Sci (2000) 1.35
Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage (2007) 1.35
The role of waist circumference in predicting disability in periretirement age adults. Int J Obes (Lond) (2006) 1.34
Hand osteoarthritis in older women is associated with carotid and coronary atherosclerosis: the AGES Reykjavik study. Ann Rheum Dis (2008) 1.33
Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol (1999) 1.32